Octave Ventures Llc — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
PlenaryAI builds customized artificial intelligence tools for physicians and clinical staff, combining biomarkers and multi-modality imaging with data analytics to support clinical decisions for patients.
AI & Machine LearningBiotechDigital HealthHealthtechBaltimore, US
Martin Pomper(Co-Founder and Scientific Advisor)Edward Herskovits(Co-Founder, CEO and CSO)Young Hoon Kim(Executive Officer)Steven Rowe(Executive Officer)
BoardMichael Kim(Director)
Valted Seq builds an end-to-end single cell analysis platform using robotics and AI, and has assembled a large database of single cell brain samples to support biomarker and therapeutic target discovery.
AI & Machine LearningBiotechDigital HealthGaithersburg, US
Dr. Valina Dawson(Co-founder)Dr. Ted Dawson(Executive Officer, Director)Seulki Lee(Co-Founder)Valina Dawson(Co-founder)Ted Dawson(Co-founder)Bardia Nezami(CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.